As of the latest SEC filings, Grace Therapeutics, Inc. (GRCE) is held by 4 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $1,853,620.50 in market value, representing a significant portion of its portfolio.
Funds holding Grace Therapeutics, Inc. (GRCE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- GRCE
- CIK:
- 0001444192
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $1,853,620.50 | 400,350 | Mar 31, 2026 | May 28, 2026 |
|
-
TIFF MULTI-ASSET FUND
|
ETF | Independent / Boutique | 0.01% | $73,593.85 | 15,895 | Mar 31, 2026 | Jun 1, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $23,899.59 | 5,571 | Feb 28, 2026 | Apr 24, 2026 |
|
VBINX
VANGUARD BALANCED INDEX FUND
|
MF | Vanguard | 0.00% | $6,046.78 | 1,306 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)